Confirmation of gene expression - based prediction of survival in non-small cell lung cancer

Clinical Cancer Research

Volumn 14, Issue 24, 2008, Pages 8213-8220

  Guo, Nancy L ^a   Wan, Ying Wooi ^a   Tosun, Kursad ^a   Lin, Hong ^a   Msiska, Zola ^b   Flynn, Daniel C ^a   Remick, Scot C ^a   Vallyathan, Val ^b   Dowlati, Afshin ^c   Shi, Xianglin ^b   Castranova, Vincent ^b   Beer, David G ^d   Qian, Yong ^b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN ENHANCER BINDING FACTOR 3; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TAL2; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; WESTERN BLOTTING; ADENOCARCINOMA; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; LUNG TUMOR; MORTALITY;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 58149356243     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-0095     Document Type: Article

References (32)

1. Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet 2000;355:479-85.
2. Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004;350:379-92.
3. Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002;8:816-24.
4. Chen HY,Yu SL, Chen CH, et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 2007;356:11 -20.
5. Potti A, Mukherjee S, Petersen R, et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570-80.
6. Dalton WS, Friend SH. Cancer biomarkers-an invitation to the table. Science 2006;312:1165-8.
7. Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas bymRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 2001;98:13790-5.
8. Bild AH, Yao G, Chang JT, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006;439:353 -7.
9. Garber ME, Troyanskaya OG, Schluens K, et al. Diver-sityofgene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A 2001;98:13784-9.
10. Powell CA, Spira A, Derti A, et al. Gene expression in lung adenocarcinomas of smokers and nonsmokers. Am J Respir Cell Mol Biol 2003;29:157-62.
11. Raponi M, Zhang Y,Yu J, et al. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res 2006;66:7466-72.
12. Wigle DA, Jurisica I, Radulovich N, et al. Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. Cancer Res 2002;62:3005 -8.
13. Tomida S, Koshikawa K, Yatabe Y, et al. Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients. Oncogene 2004;23:5360-70.
14. Larsen JE, Pavey SJ, Passmore LH, Bowman RV,Hayward NK, Fong KM. Gene expression signature predicts recurrencein lung adenocarcinoma. Clin Cancer Res 2007;13:2946 -54.
15. Hayes DN, Monti S, Parmigiani G, et al. Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts. J Clin Oncol 2006;24:5079 -90.
16. Guo L, Ma Y, Ward R, Castranova V, Shi X, QianY. Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma. Clin Cancer Res 2006;12:3344-54.
17. Bussey KJ, Kane D, Sunshine M, et al. MatchMiner: a tool for batch navigation among gene and gene product identifiers. Genome Biol 2003;4:R27.
18. Schadt EE, Li C, Su C,Wong WH. Analyzing high-density oligonucleotide gene expression array data. J Cell Biochem 2000;80:192 -202.
19. Qian Y, Liu KJ, Chen Y, Flynn DC, Castranova V, Shi X. Cdc42 regulates arsenic-induced NADPH oxidase activation and cell migration through actin filament reorganization. J Biol Chem 2005;280:3875 -84.
20. AJCC cancer staging manual. NewYork: Springer; 2002.
21. Rhodes DR,Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 2004;6:1 -6.
22. Velculescu VE, Zhang L,Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science1995;270:484-7.
23. Su AI,Welsh JB, Sapinoso LM, et al. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 2001;61:7388-93.
24. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical out come of breast cancer. Nature 2002;415:530-6.
25. Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351:2817-26.
26. McShane LM, Altman DG, Sauerbrei W,Taube SE, Gion M, Clark GM. REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 2006;100:229 -35.
27. McShane LM, Altman DG, Sauerbrei W,Taube SE, Gion M, Clark GM. Reporting recommendations for tumor marker prognostic studies (REMARK). Exp Oncol 2006;28:99-105.
28. Espinosa E, Vara JA, Redondo A, et al. Breast cancer prognosis determined by gene expression profiling: a quantitative reverse transcriptase polymerase chain reaction study. J Clin Oncol 2005; 23:7278-85.
29. Hood L, Heath JR, Phelps ME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 2004;306:640-3.
30. Mager J, Schultz RM, Brunk BP, Bartolomei MS. Identification of candidate maternal-effect genes through comparison of multiple microarray data sets. Mamm Genome 2006;17:941 -9.
31. Rajeevan MS, Vernon SD, Taysavang N, Unger ER. Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn 2001;3:26-31.
32. BosottiR,LocatelliG,HealyS,etal.Crossplatform microarray analysis for robust identification of differentially expressed genes. BMC Bioinformatics 2007; 8Suppl1:S5.